Who Owns H. Lundbeck Company?

H. Lundbeck Bundle

Get Full Bundle:

	BCG	$15	$10
	5 FORCES	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who Owns H. Lundbeck?

Understanding a company's ownership is key to grasping its strategic direction and governance. H. Lundbeck A/S, a Danish pharmaceutical firm established in 1915, has a history marked by evolution from a trading company to a specialized entity focused on brain diseases.

The company's journey, from its early days to its current status as a global player, highlights significant shifts in control and vision. A core element of its structure is its primary ownership by a research-focused foundation.

The Lundbeck Foundation, established by the company's founder, holds a significant stake, influencing its long-term commitment to scientific advancement in treating brain disorders. This foundation's role is central to the company's governance and strategic focus, ensuring a consistent mission. The company's portfolio includes treatments for conditions such as depression and Alzheimer's disease, with H. Lundbeck BCG Matrix analysis providing insights into its product performance.

H. Lundbeck A/S, a prominent pharmaceutical company, traces its origins back to August 14, 1915, when Hans Lundbeck established H. Lundbeck & Co. in Copenhagen, Denmark. Initially, the company operated as a diverse trading firm before venturing into the pharmaceutical sector in 1924.

Founding of H. Lundbeck & Co.

Hans Lundbeck founded H. Lundbeck & Co. on August 14, 1915, in Copenhagen, Denmark. The company initially engaged in trading various goods.

Entry into Pharmaceuticals

The company's pharmaceutical journey began in 1924 with the hiring of Eduard Goldschmidt. He brought crucial industry experience and secured agency contracts for medicinal products.

Development of Own Production

By the late 1930s, Lundbeck had progressed to producing its own medicinal products. An internal research department was also established during this period.

Establishment of the Lundbeck Foundation

In 1954, Grete Lundbeck, Hans Lundbeck's widow, established the Lundbeck Foundation. Its mission was to secure and expand the company's business and support scientific endeavors.

Foundation's Growing Stake

The Foundation received significant shareholdings in H. Lundbeck & Co. A/S, starting with DKK 250,000 shares in 1956 and an additional DKK 250,000 shares in 1957.

Full Ownership by the Foundation

By 1967, the Lundbeck Foundation achieved full ownership by acquiring the Goldschmidt family's 49.5% stake, marking a pivotal shift in the company's ownership structure.

The transition to full ownership by the Lundbeck Foundation in 1967 was a critical juncture for H. Lundbeck A/S. This move consolidated control under a single entity dedicated to the company's long-term growth and scientific advancement, influencing its trajectory and strategic decisions. Understanding this foundational ownership structure is key to comprehending the company's subsequent development and its approach to innovation, as detailed in discussions on the Marketing Strategy of H. Lundbeck.

Key Ownership Milestones

The ownership of H. Lundbeck A/S underwent significant changes, culminating in the Lundbeck Foundation becoming the sole owner.

• Founding by Hans Lundbeck in 1915.
• Entry into pharmaceuticals in 1924.
• Establishment of the Lundbeck Foundation in 1954.
• Lundbeck Foundation acquired full ownership in 1967.

H. Lundbeck SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The ownership journey of H. Lundbeck A/S has been significantly shaped by the Lundbeck Foundation, which acted as the sole owner from 1965 to 1999. A major shift occurred with the company's listing on the Copenhagen Stock Exchange in June 1999, which led to a dilution of the Foundation's stake to approximately 70%.

The Lundbeck Foundation, through its subsidiary Lundbeckfond Invest A/S, continues to be the largest shareholder in H. Lundbeck A/S, holding 69% of the share capital as of the end of 2023, a position maintained into 2024 and 2025. This foundation is the only entity reporting a holding exceeding 5% of the company's share capital. In June 2022, H. Lundbeck A/S transitioned to a dual-share structure, introducing A-shares and B-shares. This move aimed to bolster the company's long-term financial capabilities while ensuring the Lundbeck Foundation's continued majority control. The A-shares carry ten votes each, while B-shares carry one vote, with both share classes having identical economic rights. Consequently, as of March 12, 2025, the Lundbeck Foundation commands 76% of the total voting rights. The company's total share capital stands at DKK 995,741,110, comprising DKK 199,148,222 in A-shares and DKK 796,592,888 in B-shares. Understanding these ownership dynamics is crucial for grasping the company's governance and strategic direction, as detailed in the Brief History of H. Lundbeck.

Key Ownership Details

The Lundbeck Foundation is the dominant shareholder, influencing the company's strategic direction.

• Lundbeck Foundation holds 69% of share capital.
• Lundbeck Foundation holds 76% of voting rights as of March 12, 2025.
• The company transitioned to A-shares and B-shares in June 2022.
• A-shares carry ten votes, B-shares carry one vote.
• Approximately 30-31% of shares are publicly traded.

H. Lundbeck PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The Board of Directors at H. Lundbeck A/S is composed of eleven members, with seven elected by shareholders and four by employees. This structure ensures representation from both ownership and the workforce, guiding the company's strategic direction.

The voting power within H. Lundbeck A/S is significantly influenced by a dual-class share system, where A-shares hold ten votes and B-shares hold one vote. This arrangement, in place since June 2022, ensures that the Lundbeck Foundation, as the primary holder of A-shares, maintains substantial control over the company's decisions. As of March 12, 2025, the Lundbeck Foundation controls 76% of the total votes, underscoring its position as the majority shareholder and its role in shaping the company's long-term strategy.

Lundbeck Foundation's Influence

The Lundbeck Foundation is the primary entity influencing H. Lundbeck ownership and voting power. Its substantial stake ensures a consistent strategic vision.

• Holds 69% of the share capital as of March 12, 2025.
• Controls 76% of the voting rights.
• The dual-class share system amplifies its voting power.
• Aims for approximately 40% gender representation on the board by 2026.
• The Foundation's role is crucial for understanding Growth Strategy of H. Lundbeck.

H. Lundbeck Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Over the past few years, H. Lundbeck A/S has maintained a consistent core ownership, with the Lundbeck Foundation holding a significant majority. This stability is a key factor in the company's long-term strategic direction and its commitment to advancing brain health.

In 2022, H. Lundbeck implemented a new capital structure, introducing A-shares and B-shares to better manage its financial capacity while preserving the Lundbeck Foundation's controlling voting interest. This move is a strategic approach seen in companies aiming to balance capital raising with stakeholder control. Financially, the company achieved a record Group revenue of DKK 22,004 million in 2024, an 11% increase from the previous year, with strategic brands driving 75% of this revenue. Net profit saw a substantial 37% rise, and the company adopted a dividend policy of 30% of net profit for 2024.

Lundbeck Foundation's Dominant Stake

The Lundbeck Foundation is the primary owner of H. Lundbeck, holding 69% of the share capital and 76% of the voting rights as of March 2025. This substantial ownership ensures consistent strategic oversight and commitment to the company's mission.

Dual-Class Share Structure

A capital restructuring in 2022 introduced A-shares (10 votes) and B-shares (1 vote). This structure allows for capital growth while maintaining the Lundbeck Foundation's majority voting control, a common strategy for preserving founder influence.

Financial Performance Highlights

In 2024, H. Lundbeck reported record revenue of DKK 22,004 million, up 11% year-on-year. Strategic brands were key, growing 21% and contributing 75% of total revenue, with net profit increasing by 37%.

Strategic Acquisitions and Investments

The acquisition of Longboard Pharmaceuticals in 2024 impacted the company's debt. The Lundbeck Foundation also diversified its investments, taking a stake in WS Audiology and investing in Kvantify, reflecting broader portfolio expansion trends.

H. Lundbeck Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔